‘Live Long and Prosper’: Nimoy-Knight Foundation Selects C2N’s CEO and Co-Founder for Prestigious Award Following Alzheimer’s Disease Blood Test FDA Clearance

ST. LOUIS–(BUSINESS WIRE)– #Alzheimers–The CEO and co-founder of C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, has accepted another honor on behalf of his team to cap a month-long series of significant achievements.The Nimoy-Knight Foundation, which celebrates “Star Trek” actor and director Leonard Nimoy’s legacy of hope, inspiration, and compassion for all, chose Dr. Joel Braunstein for its Live Long & Prosper Tribute Award. The award

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.